Vibrocil

Country of origin - Switzerland, Novartis Consumer Health S.A. Switzerland
Pharm-Group - Alpha-adrenergic receptor stimulating agents

Manufacturers - Novartis (Switzerland), Novartis Consumer Health S.A. (Switzerland)
International name - Dimetindene maleate + Phenylephrine
Dosage forms - nasal gel, nasal drops, nasal spray
Composition - Active substance: dimethindene maleate and phenylephrine.
Indications for use: colds; acute and chronic rhinitis; seasonal (hay fever) and non-seasonal allergic rhinitis; acute and chronic sinusitis; acute otitis media (as an adjuvant); preparation for surgical interventions in the nasal area and elimination of swelling of the nasal mucosa and paranasal sinuses after surgery in this area. Vibrocil in gel form is preferable in the following cases: dry nasal mucosa; the presence of crusts in the nasal cavity; conditions after a nasal injury; to prevent nasal congestion at night.
Contraindications - simple atrophic rhinitis; atrophic rhinitis with foul-smelling discharge (ozena); simultaneous use of MAO inhibitors and a period of up to 14 days after their discontinuation; pregnancy; lactation (breastfeeding); children under 12 years of age with low body weight; hypersensitivity to the components of the drug. There are no clinical and experimental data on the safety of Vibrocil during pregnancy and lactation. Therefore, the drug should not be prescribed to pregnant women and nursing mothers.
Side effects - Local reactions: rarely - a transient sensation of burning and dryness of the nasal mucosa.
Interactions - Phenylephrine (like other vasoconstrictors) is contraindicated in patients currently receiving MAO inhibitors or who have received them within the previous two weeks. Caution is required when taking tricyclic antidepressants or antihypertensive drugs, such as beta-blockers, at the same time.
Overdose - Symptoms. When Vibrocil was accidentally ingested by young children, no serious side effects were observed. In most cases, there were no symptoms of overdose, but sometimes symptoms such as fatigue and abdominal pain were reported.
Special instructions - Prescribe Vibrocil with caution to patients with severe reactions to sympathomimetics, such as insomnia and dizziness. If it is necessary to use Vibrocil for more than 1 week, or if symptoms of the disease persist despite treatment, the patient should consult a doctor. Longer or excessive use of the drug may cause tachyphylaxis, swelling of the nasal mucosa and nasal congestion. Do not exceed the recommended doses of Vibrocil. Otherwise, symptoms of systemic action of the drug may appear. For children under 6 years of age, only nasal drops are used.
Literature - Directory "Vidal" 2005